Source MS Trust: Couples and families develop their own unique ways of dealing with an MS diagnosis. A recent UK study looked at how different family units affected by MS, cope with receiving MS health information.
In this study, UK researchers wanted to understand how couples and...
Innovative clinical research using robotic technology to improve balance & mobility for people living with MS
A ground-breaking clinical research trial is inviting people living with Multiple Sclerosis (MS) to take part in the evaluation of a balance exercise program using a robotic walking device.
Continuous Use of Gilenya for Up to 3 Years Can Lead to 50% Drop in Annual Relapse Rates, Real-world Study Says
Source Multiple Sclerosis News Today: Multiple sclerosis (MS) patients who began treatment with Gilenya (fingolimod) and stayed with it continuously showed a more than 50 percent reduction in annual relapse rates, a real-world study following these people for up to three years found.
Source Science Daily: Scientists have discovered a critical part of the body's immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
The iStep MS Trial research team invite you to a free seminar at Brunel University on Saturday 23rd February.
An invitation from the iStep-MS Trial Research Team: We would like to invite you to a free seminar at Brunel University London on Saturday 23rd February where we will share findings from the iStep-MS trial.
Brain Cells Key to Myelin Grown in Lab and Show Long-Term Survival Essential to Research, Study Reports
Source Multiple Sclerosis News Today: Stem cells tweaked in the laboratory have allowed researchers, reportedly for a first time, to generate and maintain ball-shaped cultures — called spheroids — of human brain cells in 3D that contain oligodendrocytes, the cells that produce myelin, along with...
Source MS Trust: A letter signed by the MS Society, MS Trust, Shift MS and leading neurologists calls on NICE, NHS England and drug manufacturer Roche to make ocrelizumab available for people with primary progressive MS.
Back in September, NICE announced that it would not be recommending...
Source Independent Living: Exercise is frequently cited as a good way of helping to prevent falls, and now we have strong evidence that a programme of exercise can indeed prevent falls amongst older people living in the community.
Source MS Trust: People with relapsing remitting MS starting early treatment with a disease modifying drug have a lower risk of developing secondary progressive MS, according to a study of medical records.